Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Arthritis, Rheumatoid × Rituximab × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Non-Hodgkin 5 Leukemia, Lymphocytic, Chronic, B-Cell 4 Lymphoma, B-Cell, Marginal Zone 2 Waldenstrom Macroglobulinemia 1 Sjogren's Syndrome 1 Neoplasms 1 Neoplasm, Residual 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lymphohistiocytosis, Hemophagocytic 1 Lymphatic Diseases 1 Leukemia, B-Cell 1 Leukemia 1 Heart Failure 1 Arthritis, Rheumatoid 1

Interventions

Etanercept 9 Adalimumab 9 Methotrexate 3 Infliximab 3 tofacitinib 2 Leflunomide 2 Abatacept 2 tocilizumab 1 sarilumab 1 golimumab 1 entecavir 1 Tumor Necrosis Factor Inhibitors 1 Sulfasalazine 1 Rituximab 1 Prednisone 1 Licensure 1 Hydroxychloroquine 1 Glucocorticoids 1 Folic Acid 1 Chloroquine 1 Certolizumab Pegol 1 Azathioprine 1 Antirheumatic Agents 1 Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01295151 2016-11-02

SWITCH

University of Leeds

Phase 4 Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡